大博医疗2025年1-6月净利润为2.44亿元，较去年同期增长76.69%

Core Insights - The company reported a total revenue of 1.21 billion yuan for the first half of 2025, representing a year-on-year growth of 25.55% [1] - Net profit reached 244 million yuan, marking a significant increase of 76.69% compared to the same period last year [1] - Earnings per share stood at 0.6007 yuan, with a return on equity of 7.6% and operating cash flow per share of 0.6348 yuan [1] - The gross profit margin for sales was recorded at 71.01% [1] Company Overview - The company, established in 2004, is located in Xiamen, specializing in the production, research, and sales of high-value medical consumables [1] - It has a registered capital of 414 million yuan, with Lin Zhixiong as the legal representative [1] - The company has made investments in 24 enterprises and participated in 942 bidding projects [1] - It holds 24 trademark registrations and 340 patents, along with 260 administrative licenses [1]